The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease
Open accessAbstract
Gut microbiota shows host-specific diversity and temporal stability and significantly contributes to maintenance of a healthy gut. However, in inflammatory bowel disease, this microbiota has been implicated as a contributory factor to the illness. This study compared bacterial dynamics in Crohn's disease patients to those in a control group using a culture-independent method to assess the temporal stability, relative diversity, and similarity of the dominant fecal microbiota, Clostridium spp., Bacteroides spp., Bifidobacterium spp., and lactic acid bacteria spp. (LAB) for all individuals. Fecal samples were collected over several time points from individuals with Crohn's disease who were in remission ( n = 11), from Crohn's disease patients who relapsed into an active Crohn's disease state ( n = 5), and from a control group ( n = 18). Denaturing gradient gel electrophoresis profiles were generated for the different microbial groups by specifically targeting different regions of the 16S rRNA gene and were compared on the basis of similarity and diversity. The temporal stability of dominant species for all Crohn's disease patients was significantly lower ( P < 0.005) than that for the control group. Analysis of group-specific profiles for Bifidobacterium spp. found that they were similar in all samples, while the diversity of the LAB varied significantly between the groups, but temporal stability was not significantly altered. We observed significant changes in two functionally important mutualistic groups of bacteria, viz., Clostridium and Bacteroides spp., which may have implications for the host's gut health, since some genera are involved in production of short-chain fatty acid, e.g., butyrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In fact, as with IBS (tables 2 and 3), faecal166–171 and mucosal-associated dysbiosis167 172–178 has been described IBD.”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 48,949
SIMPSON, E. H. (1949) · Nature · doi:10.1038/163688a0 · Cited by 14,164
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
Amann, R., Ludwig, W., & SCHLEIFER, K. H. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.1.143-169.1995 · Cited by 9,093
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“In this exploratory investigation, we report on the temporal stability and diversity of the dominant bacterial species, the Bacteroides fragilis subgroup (which is involved in metabolism of indigestible dietary polysaccharides [2] and may play a role in inflammatory bowel disease [30]), the Clostridium leptum subgroup…”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Research works printed but not linked: 4
- 10.1128/mr.59.1.143-169.1995 · doi:10.1128/mr.59.1.143-169.1995 · Paper page
- Boclé, J.-C., and C. Thomann. 2005. Effects of probiotics and prebiotics on flora and immunity in adults, p. 59-128. In L'Agence Française de Sécurité Sanitaire des Aliments report. L'Agence Française de Sécurité Sanitaire des Aliments, Maisons-Alfort, France.
- 10.1111/j.1574-6941.2002.tb00911.x · doi:10.1111/j.1574-6941.2002.tb00911.x · Paper page
- Sambrook J. and D. Russell. 2000. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y.
Cited by
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
“Similar to the findings in animal studies, dysbiosis has been implicated in IBD in humans, with several studies showing a significant alteration in the microbiota of patients with IB”
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160
Moving pictures of the human microbiome
Caporaso, J. G., Lauber, C. L., Costello, E. K., Berg-Lyons, D., Gonzalez, A., Stombaugh, J., Knights, D., Gajer, P., Ravel, J., Fierer, N., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-5-r50 · Cited by 1,138
“Taxo-nomic summaries of the persistent and transient groups for all body sites from both individuals are presented in Additional file 16.”
BackgroundDysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
Willing, B. P., Dicksved, J., Halfvarson, J., Andersson, A. F., Lucio, M., Zheng, Z., Järnerot, G., Tysk, C., Jansson, J. K., & Engstrand, L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.049 · Cited by 1,032
Microbial genes and pathways in inflammatory bowel disease
Schirmer, M., Garner, A., Vlamakis, H., & Xavier, R. J. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0213-6 · Cited by 956
Brain-gut-microbe communication in health and disease
Grenham, S., Clarke, G., Cryan, J. F., & Dinan, T. G. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00094 · Cited by 952
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J., & Martinez-Medina, M. (2017) · The ISME Journal · doi:10.1038/ismej.2016.176 · Cited by 874
“In particular, fewer types of Firmicutes, mostly from Ruminococcaceae, were observed in feces of CD patients (Scanlan et al., 2006).”
BackgroundDistinct composition of gut microbiota during pregnancy in overweight and normal-weight women
Collado, M. C., Isolauri, E., Laitinen, K., & Salminen, S. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.894 · Cited by 866
The gut microbiota and inflammatory bowel disease
Matsuoka, K., & Kanai, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0454-4 · Cited by 804
“The most consistent observations of altered composition of the gut microbiota in IBD patients are a reduction in Firmicutes and an increase in Proteobacteria [6, 7, 10–12].”
Walter, J. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00753-08 · Cited by 751
Walker, A. W., Sanderson, J. D., Churcher, C., Parkes, G. C., Hudspith, B. N., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 726
“We also demonstrated a reduction in bacterial diversity within IBD patients compared to controls and this is in agreement with several previous studies [24-27,56,57].”
BackgroundResultIntestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
“Healthy adults (n = 10) Probiotic: milk powder containing L. rhamnosus DR20 Faeces Conventional culturing FISH DGGE Probiotic-treated group: No significant effect on dominant microbiota composition Tannock et al. (2000) Healthy adults (n = 30) Probiotic: B. animalis subsp. lactis Bb-12 Prebiotic: GOS Synbiotic: GOS an…”
MethodInfluentialHomeostasis of the gut barrier and potential biomarkers
Wells, J. M., Brummer, R. J., Derrien, M., MacDonald, T. T., Troost, F., Cani, P. D., Theodorou, V., Dekker, J., Méheust, A., de Vos, W. M., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2015 · Cited by 620
Microbial Ecology along the Gastrointestinal Tract
Hillman, E. T., Lu, H., Yao, T., & Nakatsu, C. H. (2017) · Microbes and environments · doi:10.1264/jsme2.me17017 · Cited by 580
“Similar to Bacteria, large variations have been noted in viruses found in the oral cavity among subjects (151).”
BackgroundInfluentialNOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye-Crespin, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62236 · Cited by 572
“In particular, CD is associated with a greater preponderance of certain Bacteroidetes and a lower abundance of Firmicutes (9, 10).”
(2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.014 · Cited by 536
Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., & Young, V. B. (2009) · Infection and Immunity · doi:10.1128/iai.01520-08 · Cited by 550
“A number of studies have indicated that an individual’s gut microbiota can have a relatively stable community composition over a period of months to years (36, 49, 57, 62).”
BackgroundWang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01500-13 · Cited by 509
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503
“Several studies have documented marked alterations in the gut microbiota of patients with IBD (Giaffer et al., 1991; Gophna et al., 2006; Krook et al., 1981; Lepage et al., 2005; Mangin et al., 2004; Manichanh et al., 2006; Van de Merwe et al., 1988; Prindiville et al., 2004; Scanlan et al., 2006; Seksik et al., 2003).”
BackgroundHost–Bacterial Symbiosis in Health and Disease
Chow, J., Lee, S. M., Shen, Y., Khosravi, A., & Mazmanian, S. K. (2010) · Advances in Immunology · doi:10.1016/b978-0-12-381300-8.00008-3 · Cited by 469
“Temporal stability and diversity of the gut microbiota composition in IBD patients were revealed to be significantly decreased compared to non-IBD controls (Scanlan et al., 2006).”
BackgroundPeyer's Patches: The Immune Sensors of the Intestine
Jung, C., Hugot, J.-P., & Barreau, F. (2010) · International Journal of Inflammation · doi:10.4061/2010/823710 · Cited by 465
“Actually, studies on CD microbiota have found evidence for decline in bacterial diversity in CD patients, compared to controls [121, 122].”
BackgroundMolecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes
Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., et al. (2010) · Current Microbiology · doi:10.1007/s00284-010-9582-9 · Cited by 462
From Structure to Function: the Ecology of Host-Associated Microbial Communities
Robinson, C. J., Bohannan, B. J. M., & Young, V. B. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-10 · Cited by 457
Molecular analysis of the gut microbiota of identical twins with Crohn's disease
Dicksved, J., Halfvarson, J., Rosenquist, M., Järnerot, G., Tysk, C., Apajalahti, J., Engstrand, L., & Jansson, J. K. (2008) · The ISME Journal · doi:10.1038/ismej.2008.37 · Cited by 459
“are dominant members of the fecal microbiota (Seksik et al., 2003; Ott et al., 2004; Scanlan et al., 2006) and our Bacteroides clone sequences from the same material had the same TRF sizes (see below).”
BackgroundResultInfluentialWilling, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Pathobionts of the gastrointestinal microbiota and inflammatory disease
Chow, J., Tang, H., & Mazmanian, S. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.010 · Cited by 448
The Macaque Gut Microbiome in Health, Lentiviral Infection, and Chronic Enterocolitis
McKenna, P., Hoffmann, C., Minkah, N., Aye, P. P., Lackner, A., Liu, Z., Lozupone, C. A., Hamady, M., Knight, R., & Bushman, F. D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040020 · Cited by 437
Gradel, K. O., Nielsen, H. L., Schønheyder, H. C., Ejlertsen, T., Kristensen, B., & Nielsen, H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.001 · Cited by 424
Complex host genetics influence the microbiome in inflammatory bowel disease
Knights, D., Silverberg, M. S., Weersma, R. K., Gevers, D., Dijkstra, G., Huang, H., Tyler, A. D., van Sommeren, S., Imhann, F., Stempak, J. M., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0107-1 · Cited by 418
“Shifts in taxonomic composition and metabolic capabilities of the IBD microbiome are both now beginning to be defined [4-9].”
Gastrointestinal microbiology enters the metagenomics era
Frank, D. N., & Pace, N. R. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f2b0e8 · Cited by 405
Microbes and the gut‐brain axis
Bercik, P., Collins, S. M., & Verdu, E. F. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01906.x · Cited by 417
Jalanka-Tuovinen, J., Salonen, A., Nikkilä, J., Immonen, O., Kekkonen, R., Lahti, L., Palva, A., & de Vos, W. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023035 · Cited by 340
Kverka, M., Zakostelska, Z., Klimesova, K., Sokol, D., Hudcovic, T., Hrncir, T., Rossmann, P., Mrazek, J., Kopecny, J., Verdu, E. F., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04286.x · Cited by 335
The human gut microbiome: current knowledge, challenges, and future directions
Dave, M., Higgins, P. D., Middha, S., & Rioux, K. P. (2012) · Translational Research · doi:10.1016/j.trsl.2012.05.003 · Cited by 336
Dziarski, R., Park, S. Y., Kashyap, D. R., Dowd, S. E., & Gupta, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146162 · Cited by 328
Human Gut Microbiota: Repertoire and Variations
Lagier, J.-C., Million, M., Hugon, P., Armougom, F., & Raoult, D. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00136 · Cited by 329
“…cancer (Scanlan et al., 2008), necrotizing enterocolitis (Siggers et al., 2008), Crohn’s disease (De Hertogh et al., 2006; Manichanh et al., 2006; Scanlan et al., 2006), and metabolic diseases such as type II diabetes (Larsen et al., 2010) and obesity (Ley et al., 2006b; Turnbaugh et al., 2006,…”
Takaishi, H., Matsuki, T., Nakazawa, A., Takada, T., Kado, S., Asahara, T., Kamada, N., Sakuraba, A., Yajima, T., Higuchi, H., et al. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.07.016 · Cited by 325
Role of the microbiota in inflammatory bowel diseases
Nagalingam, N. A., & Lynch, S. V. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21866 · Cited by 315
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease
Fujimoto, T., Imaeda, H., Takahashi, K., Kasumi, E., Bamba, S., Fujiyama, Y., & Andoh, A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12073 · Cited by 304
O'Shea, E. F., Cotter, P. D., Stanton, C., Ross, R. P., & Hill, C. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.05.025 · Cited by 305
“Indeed, fluctuations in the composition of the intestinal ecosystem have been associated with various disease states including inflammatory immune disorders, obesity and cancer (Backhed, 2010; Davis and Milner, 2009; Scanlan et al., 2006).”
BackgroundA Pathobiont of the Microbiota Balances Host Colonization and Intestinal Inflammation
Chow, J., & Mazmanian, S. K. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.03.004 · Cited by 291
“A recent metagenomic (cultureindependent analysis) case-control study comparing the microbiota of patients with IBD to that of non-IBD controls, revealed a statistically significant difference between the microbial compositions (Frank et al., 2007).”
BackgroundInfluentialCarroll, I. M., Ringel-Kulka, T., Keku, T. O., Chang, Y.-H., Packey, C. D., Sartor, R. B., & Ringel, Y. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00154.2011 · Cited by 292
Forgotten fungi—the gut mycobiome in human health and disease
Huseyin, C. E., O’Toole, P. W., Cotter, P. D., & Scanlan, P. D. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw047 · Cited by 278
“This includes the gut microbiota, particularly the bacterial, andmore recently, the fungal components of the community (Scanlan et al. 2006; Moyes and Naglik 2012; Sokol et al. 2016).”
BackgroundSelf-citationLong‐term monitoring of the human intestinal microbiota composition
Rajilić‐Stojanović, M., Heilig, H. G. H. J., Tims, S., Zoetendal, E. G., & de Vos, W. M. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12023 · Cited by 268
The gut microbiome: the role of a virtual organ in the endocrinology of the host
Evans, J. M., Morris, L. S., & Marchesi, J. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0131 · Cited by 264
“Many ecological analyses of the colonic microbiota have shown that while it is relatively stable (Scanlan et al. 2006, Jalanka-Tuovinen et al. 2011, Kolmeder et al. 2012), it can be significantly perturbed by antibiotics (Dethlefsen et al. 2008, Jernberg et al. 2010), diet (Claesson et al. 2012,…”
BackgroundSelf-citationChahwan, B., Kwan, S., Isik, A., van Hemert, S., Burke, C., & Roberts, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.097 · Cited by 256
“disease (Scanlan et al., 2006), and depression (Jiang et al.”
Microbial community and metabolomic comparison of irritable bowel syndrome faeces
Ponnusamy, K., Choi, J. N., Kim, J., Lee, S.-Y., & Lee, C. H. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.028126-0 · Cited by 247
“The Simpson index of dominance was higher in nIBS samples, which is in contrast to other intestinal diseases, and it was not found to be significantly different between Crohn’s disease and control groups (Scanlan et al., 2006).”
Clooney, A. G., Eckenberger, J., Laserna-Mendieta, E., Sexton, K. A., Bernstein, M. T., Vagianos, K., Sargent, M., Ryan, F. J., Moran, C., Sheehan, D., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321106 · Cited by 244
Self-citationCulture‐independent analysis of the gut microbiota in colorectal cancer and polyposis
Scanlan, P. D., Shanahan, F., Clune, Y., Collins, J. K., O'Sullivan, G. C., O'Riordan, M., Holmes, E., Wang, Y., & Marchesi, J. R. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01503.x · Cited by 245
“inflammatory bowel disease (IBD), reductions in diversity have been shown (Manichanh et al., 2006; Scanlan et al., 2006), but the concept of increased bacterial diversity has not been routinely addressed.”
BackgroundSelf-citationA Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
Codling, C., O’Mahony, L., Shanahan, F., Quigley, E. M. M., & Marchesi, J. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0934-x · Cited by 243
Self-citationRodriguez-Palacios, A., Harding, A., Menghini, P., Himmelman, C., Retuerto, M., Nickerson, K. P., Lam, M., Croniger, C. M., McLean, M. H., Durum, S. K., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy060 · Cited by 225
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
Abegunde, A. T., Muhammad, B. H., Bhatti, O., & Ali, T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6296 · Cited by 229
A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome
Gloux, K., Berteau, O., El oumami, H., Béguet, F., Leclerc, M., & Doré, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000066107 · Cited by 226
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Noor, S. O., Ridgway, K., Scovell, L., Kemsley, E. K., Lund, E. K., Jamieson, C., Johnson, I. T., & Narbad, A. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-134 · Cited by 227
“Many of the studies to date have monitored changes in DGGE patterns by comparing the presence and absence of bands, or changes in the intensity of a single band on the same gel [32].”
BackgroundMicrobial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease
Sepehri, S., Kotlowski, R., Bernstein, C. N., & Krause, D. O. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20101 · Cited by 225
Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery
Petricevic, L., Domig, K. J., Nierscher, F. J., Sandhofer, M. J., Fidesser, M., Krondorfer, I., Husslein, P., Kneifel, W., & Kiss, H. (2014) · Scientific Reports · doi:10.1038/srep05136 · Cited by 222
Heat stress mediates changes in fecal microbiome and functional pathways of laying hens
Zhu, L., Liao, R., Wu, N., Zhu, G., & Yang, C. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9465-8 · Cited by 221
Bruzzese, E., Callegari, M. L., Raia, V., Viscovo, S., Scotto, R., Ferrari, S., Morelli, L., Buccigrossi, V., Lo Vecchio, A., Ruberto, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087796 · Cited by 217
Ki Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.-D., Woong Lee, H., Joon Kim, H., Hyuk, J., Kyung Chang, S., Kim, K., Chung, W.-S., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31823712b1 · Cited by 216
Analysis of bacterial bowel communities of IBD patients: What has it revealed?
Sokol, H., Lay, C., Seksik, P., & Tannock, G. W. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20392 · Cited by 216
The intestinal microbiota: its role in health and disease
Biedermann, L., & Rogler, G. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-014-2476-2 · Cited by 211
“specific differences, such as 16S RNA [46, 161, 167, 168].”
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
Wieland, A., Frank, D. N., Harnke, B., & Bambha, K. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13376 · Cited by 207
Scanlan, P. D., Shanahan, F., & Marchesi, J. R. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-79 · Cited by 206
Self-citationValcheva, R., Koleva, P., Martínez, I., Walter, J., Gänzle, M. G., & Dieleman, L. A. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1526583 · Cited by 205
Wright, E. K., Kamm, M. A., Teo, S. M., Inouye, M., Wagner, J., & Kirkwood, C. D. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000382 · Cited by 202
Martinez, R. C. R., Bedani, R., & Saad, S. M. I. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515003864 · Cited by 203
“Fluctuations in the composition of the intestinal ecosystem have been associated with various diseases, including imunnoin fl ammatory disorders, obesity and cancer (18 – 21) .”
Therapeutic modulation of intestinal dysbiosis
Walker, A. W., & Lawley, T. D. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.008 · Cited by 200
Martínez, I., Muller, C. E., & Walter, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069621 · Cited by 181
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 180
“Similar results were obtained in another study on UC patients during clinical remission (Ott et al., 2008b) and in a study on CD patients (Scanlan et al., 2006).”
ResultThe altered gut microbiota in adults with cystic fibrosis
Burke, D. G., Fouhy, F., Harrison, M. J., Rea, M. C., Cotter, P. D., O’Sullivan, O., Stanton, C., Hill, C., Shanahan, F., Plant, B. J., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0968-8 · Cited by 179
Self-citationThe role of mucosal immunity and host genetics in defining intestinal commensal bacteria
Hansen, J., Gulati, A., & Sartor, R. B. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32833f1195 · Cited by 177
Aldars-García, L., Chaparro, M., & Gisbert, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050977 · Cited by 178
“[12] 2004 Not naïve NA 9 NA 10 Active Biopsy NA Crosssectional Culture, FISH Bacteria UC Only differences in bifidobacteria were statistically significant.”
BackgroundSanz, Y., Sánchez, E., Marzotto, M., Calabuig, M., Torriani, S., & Dellaglio, F. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00337.x · Cited by 173
“DGGE analysis of faeces from Crohn’s disease patients and controls indicated that the diversity of lactic acid bacteria varied significantly between the groups (Scanlan et al., 2006).”
BackgroundPackey, C. D., & Sartor, R. B. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01962.x · Cited by 171
Tavakoli, P., Vollmer-Conna, U., Hadzi-Pavlovic, D., & Grimm, M. C. (2021) · Public Health Reviews · doi:10.3389/phrs.2021.1603990 · Cited by 168
Inflammatory bowel disease, gut bacteria and probiotic therapy
Reiff, C., & Kelly, D. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.004 · Cited by 164
“relapse and active disease state is reduced in CD patients (Scanlan et al., 2006), implying that fluctuating microbial populations in CD may account for the overactive immune response triggered by a constantly changing microbiota.”
BackgroundConstante, M., Fragoso, G., Calvé, A., Samba-Mondonga, M., & Santos, M. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01809 · Cited by 161
“…formulations (Constante et al., 2017), is sufficient in replicating several aspects of the dysbiosis found in IBD patients (Manichanh et al., 2006; Scanlan et al., 2006; Frank et al., 2007; Peterson et al., 2008; Walters et al., 2014; Winter and Baumler, 2014) and in the DSS mouse model of…”
BackgroundDeterminants of IBD Heritability: Genes, Bugs, and More
Turpin, W., Goethel, A., Bedrani, L., & Croitoru, M. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy085 · Cited by 162
Intestinal microbiota: A source of novel biomarkers in inflammatory bowel diseases?
Berry, D., & Reinisch, W. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.005 · Cited by 183
Hoffmann, C., Hill, D. A., Minkah, N., Kirn, T., Troy, A., Artis, D., & Bushman, F. (2009) · Infection and Immunity · doi:10.1128/iai.00493-09 · Cited by 142
Diversity of the gut microbiota and eczema in early life
Forno, E., Onderdonk, A. B., McCracken, J., Litonjua, A. A., Laskey, D., Delaney, M. L., DuBois, A. M., Gold, D. R., Ryan, L. M., Weiss, S. T., et al. (2008) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-6-11 · Cited by 132
“Abnormalities in quantity or composition of the fecal microbiota have been linked to diseases such as ulcerative colitis [41], Crohn's disease[42,43], and celiac disease [44,45].”
BackgroundMasetti, G., Moshkelgosha, S., Köhling, H.-L., Covelli, D., Banga, J. P., Berchner‐Pfannschmidt, U., Horstmann, M., Díaz‐Cano, S. J., Goertz, G.-E., Plummer, S. F., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0478-4 · Cited by 137
“Over the years, the gut microbiota has been associated with several diseases [14 – 17] and its confounding role in establishing or reproducing disease phenotype in murine models has also been proposed [18].”
Self-citationAssociation of gut microbiota with post-operative clinical course in Crohn’s disease
Dey, N., Soergel, D. A. W., Repo, S., & Brenner, S. E. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-131 · Cited by 138
“Consistent with prior reports suggesting translational utility of gut microbial profiling in Crohn’s disease [9,48], we show here that patients experiencing recurrence of inflammation after surgical resection of all diseased bowel have distinct diversity profiles relative to patients who remain in remission.”
ResultIdentifying Microorganisms Involved in Specific Pathogen Suppression in Soil
James, & Becker, J. O. (2007) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.45.062806.094354 · Cited by 141
“[For additional examples of temporal shifts in microbial communities associated with specific processes see (31, 42, 43, 45, 56, 66, 72, 80, 93).”
BackgroundScanlan, P. D., Shanahan, F., & Marchesi, J. R. (2009) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2009.00709.x · Cited by 127
“Although the gastrointestinal microbiota constitute a principal aspect of human nutrition and health (Xu & Gordon, 2003), alterations in the microbiota are evident in several studies investigating disease processes of the gastrointestinal tract (Malinen et al., 2005; Scanlan et al., 2006; Frank et al., 2007; Ott et al…”
BackgroundSelf-citationMolecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients
Ishaq, H. M., Mohammad, I. S., Shahzad, M., Ma, C., Raza, M. A., Wu, X., Guo, H., Shi, P., & Xu, J. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24151 · Cited by 130
Giuffrè, M., Campigotto, M., Campisciano, G., Comar, M., & Crocè, L. S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2019 · Cited by 126
Vermeiren, J., den Abbeele, P. V., Laukens, D., Vigsnæs, L. K., Vos, M. D., Boon, N., & de Wiele, T. V. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2011.01252.x · Cited by 139
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114
“Studies on fecal (54) and mucosal (9) samples from inflammatory bowel disease (IBD) patients revealed a functional reduction of the Bacteroides fragilis subgroup, which potentially shields the host against Escherichia coli-induced colitis.”
BackgroundResultInfluentialBlastocystis: past pitfalls and future perspectives
Scanlan, P. D. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.05.001 · Cited by 133
Self-citationIshaq, H. M., Mohammad, I. S., Guo, H., Shahzad, M., Hou, Y. J., Ma, C., Naseem, Z., Wu, X., Shi, P., & Xu, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.101 · Cited by 127
Westbrook, A. M., Szakmary, A., & Schiestl, R. H. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.03.001 · Cited by 130
“It has also been observed that microbial composition and metabolic activity are altered in Crohn's disease and ulcerative colitis [235-238].”
BackgroundAltered Fecal Microbiota in Paediatric Inflammatory Bowel Disease
Maukonen, J., Kolho, K., Paasela, M., Honkanen, J. K., Klemetti, P., Vaarala, O., & Saarela, M. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv147 · Cited by 119
Metadata
- Authors
- Scanlan, P. D., Shanahan, F., O'Mahony, C., & Marchesi, J. R.
- Affiliations
- National University of Ireland (IE)
- Alimentary Pharmabiotic Centre, National University of Ireland, University College Cork, Cork, Ireland
- Corresponding author
- Marchesi, Julian R.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 44
- Issue
- 11
- Pages
- 3980-3988
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1698357
- OpenAlex
- W2144413511
- Cited by
- 330
- References
- 72
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 26 · 2023: 12 · 2022: 18 · 2021: 12 · 2020: 16 · 2019: 15 · 2018: 20 · 2017: 11 · 2016: 16 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 24
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Update notices
- correction (2007-05-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Crohn's disease, gut microbiota, fecal microbiota, temporal stability, inflammatory bowel disease, Clostridium, Bacteroides, Bifidobacterium, lactic acid bacteria, remission, recurrence, microbial diversity, 16S rRNA gene, short-chain fatty acids, butyrate
- MeSH terms
- Adult, Aged, Bacteria, Bacteroides fragilis, Bifidobacterium, Clostridium, Crohn Disease, Feces, Female, Humans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.